Clinigen expecting good growth from all three operations in second half

By Andrew Scott / January 17, 2018 / www.proactiveinvestors.co.uk / Article Link

Clinigen Group PLC (LON:CLIN) chief executive Shaun Chilton discusses the group's half year trading update with Proactive's Andrew Scott.

Chilton says they're well positioned for another year of growth with trading at the halfway stage in line with expectations.

Revenues were up 28% year-on-year, although the figure was distorted by what are called 'pass through costs' associated with the unlicensed medicines it accesses on behalf of patients in need.

 Meet Netscientific PLC, discoverIE Group plc, Itaconix Plc and Realm Therapeutics plc at our event, London, 25 January 2018.Register here >>

Recent News

Gold stocks lead the large cap miners by far over H1/25

July 07, 2025 / www.canadianminingreport.com

Gold stocks up as the metal price and equities gain

July 07, 2025 / www.canadianminingreport.com

Mixed outlook for gold as it remains range bound for past three months

June 30, 2025 / www.canadianminingreport.com

Gold stocks down on flat metal price

June 30, 2025 / www.canadianminingreport.com

Gold stocks down on metal decline

June 23, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok